Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 20/20 | 0.66 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30096808 | 1.00 | STING1 (0.66) | STING1TBK1 | |
| SCHEMBL27134522 | 1.00 | STING1 (0.66) | STING1TBK1 | |
| SCHEMBL21158072 | 0.95 | STING1 (0.70) | STING1TBK1 | |
| SCHEMBL30096847 | 0.95 | STING1 (0.70) | STING1TBK1 | |
| SCHEMBL27125617 | 0.95 | STING1 (0.70) | STING1TBK1 | |
| SCHEMBL22150350 | 0.92 | STING1 (0.75) | STING1TBK1 | |
| SCHEMBL21616389 | 0.91 | STING1 (0.77) | STING1TBK1 | |
| SCHEMBL29689500 | 0.91 | STING1 (0.77) | STING1TBK1 | |
| SCHEMBL22149041 | 0.89 | STING1 (0.68) | STING1TBK1 | |
| SCHEMBL22121341 | 0.89 | STING1 (0.70) | STING1TBK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240132493-A1 | IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS | FULGENT GENETICS INC (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240002383-A1 | COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS | FUDAN UNIVERSITY (CN) | 2024-01-04 | — | — | US | disclosed |
| CN-116940574-A | Compounds and their use as vaccine adjuvants | 福君基因公司 | 2023-10-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002383-A1 | COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS | CTSA, ALOX5AP, ALOX15 | STING1 4/4885TBK1 31/4885 |
| US-20240132493-A1 | IMIDAZOPYRIDINE DERIVATIVES AS STING AGONISTS | STING1, IRF3, MAVS | STING1 1/4885TBK1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.